Alaunos Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Alaunos Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Alaunos Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 363 %, a 72.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 363 +153 +72.7% Jun 30, 2024
Q1 2024 356 +148 +71.7% Mar 31, 2024
Q4 2023 272 +42.8 +18.7% Dec 31, 2023
Q3 2023 243 -31.3 -11.4% Sep 30, 2023
Q2 2023 210 -122 -36.8% Jun 30, 2023
Q1 2023 207 -216 -51.1% Mar 31, 2023
Q4 2022 229 -263 -53.5% Dec 31, 2022
Q3 2022 274 -269 -49.5% Sep 30, 2022
Q2 2022 332 -362 -52.1% Jun 30, 2022
Q1 2022 423 -352 -45.4% Mar 31, 2022
Q4 2021 492 -420 -46% Dec 31, 2021
Q3 2021 543 -411 -43.1% Sep 30, 2021
Q2 2021 694 -326 -32% Jun 30, 2021
Q1 2021 775 -169 -17.9% Mar 31, 2021
Q4 2020 911 +60.6 +7.12% Dec 31, 2020
Q3 2020 954 +91.6 +10.6% Sep 30, 2020
Q2 2020 1.02K +714 +233% Jun 30, 2020
Q1 2020 944 +648 +219% Mar 31, 2020
Q4 2019 851 +563 +195% Dec 31, 2019
Q3 2019 863 +601 +229% Sep 30, 2019
Q2 2019 307 -259 -45.8% Jun 30, 2019
Q1 2019 296 -323 -52.2% Mar 31, 2019
Q4 2018 288 -296 -50.7% Dec 31, 2018
Q3 2018 262 -387 -59.6% Sep 30, 2018
Q2 2018 566 -108 -16.1% Jun 30, 2018
Q1 2018 619 -57.5 -8.49% Mar 31, 2018
Q4 2017 584 -168 -22.3% Dec 31, 2017
Q3 2017 649 -148 -18.6% Sep 30, 2017
Q2 2017 674 -56 -7.66% Jun 30, 2017
Q1 2017 676 -76.7 -10.2% Mar 31, 2017
Q4 2016 752 -59.2 -7.3% Dec 31, 2016
Q3 2016 797 +62.7 +8.54% Sep 30, 2016
Q2 2016 730 -18.7 -2.5% Jun 30, 2016
Q1 2016 753 +122 +19.3% Mar 31, 2016
Q4 2015 811 +300 +58.6% Dec 31, 2015
Q3 2015 734 +112 +18% Sep 30, 2015
Q2 2015 749 +206 +37.8% Jun 30, 2015
Q1 2015 631 +222 +54.2% Mar 31, 2015
Q4 2014 511 +189 +58.9% Dec 31, 2014
Q3 2014 622 +335 +117% Sep 30, 2014
Q2 2014 544 +194 +55.5% Jun 30, 2014
Q1 2014 409 -51.6 -11.2% Mar 31, 2014
Q4 2013 322 -285 -47% Dec 31, 2013
Q3 2013 287 -408 -58.7% Sep 30, 2013
Q2 2013 350 -497 -58.7% Jun 30, 2013
Q1 2013 461 -570 -55.3% Mar 31, 2013
Q4 2012 607 Dec 31, 2012
Q3 2012 695 Sep 30, 2012
Q2 2012 847 Jun 30, 2012
Q1 2012 1.03K Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.